Mr. Speaker, every one of us in this House has a loved one who has fought cancer, and all of us know how important it is that we continue to honour Terry Fox's legacy with bold ambition. Our investment in precision oncology is an investment in a more personalized approach to cancer care, one that reduces harmful side effects and makes the treatment more likely to work. No one wants to lose a loved one to cancer, and this investment should give hope to all of us.
In the House of Commons on September 25th, 2026. See this statement in context.